602 related articles for article (PubMed ID: 25017523)
21. Investigational and unproven therapies in atopic dermatitis.
Ong PY; Boguniewicz M
Immunol Allergy Clin North Am; 2010 Aug; 30(3):425-39. PubMed ID: 20670823
[TBL] [Abstract][Full Text] [Related]
22. New insights into atopic dermatitis.
Leung DY; Boguniewicz M; Howell MD; Nomura I; Hamid QA
J Clin Invest; 2004 Mar; 113(5):651-7. PubMed ID: 14991059
[TBL] [Abstract][Full Text] [Related]
23. The Role of Th17-Related Cytokines in Atopic Dermatitis.
Sugaya M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075269
[TBL] [Abstract][Full Text] [Related]
24. Administration of poly(I:C) improved dermatophagoides farinae-induced atopic dermatitis-like skin lesions in NC/Nga mice by the regulation of Th1/Th2 balance.
Kim CH; Park CD; Lee AY
Vaccine; 2012 Mar; 30(14):2405-10. PubMed ID: 22119586
[TBL] [Abstract][Full Text] [Related]
25. Pyridone 6, a pan-JAK inhibitor, ameliorates allergic skin inflammation of NC/Nga mice via suppression of Th2 and enhancement of Th17.
Nakagawa R; Yoshida H; Asakawa M; Tamiya T; Inoue N; Morita R; Inoue H; Nakao A; Yoshimura A
J Immunol; 2011 Nov; 187(9):4611-20. PubMed ID: 21957150
[TBL] [Abstract][Full Text] [Related]
26. Mechanism underlying the effect of combined therapy using glucosamine and low-dose cyclosporine A on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
Kim CH; Choi YS; Cheong KA; Lee AY
Int Immunopharmacol; 2013 Feb; 15(2):424-32. PubMed ID: 23352844
[TBL] [Abstract][Full Text] [Related]
27. Immunology of atopic eczema: overcoming the Th1/Th2 paradigm.
Eyerich K; Novak N
Allergy; 2013 Aug; 68(8):974-82. PubMed ID: 23889510
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
Kaesler S; Volz T; Skabytska Y; Köberle M; Hein U; Chen KM; Guenova E; Wölbing F; Röcken M; Biedermann T
J Allergy Clin Immunol; 2014 Jul; 134(1):92-9. PubMed ID: 24698321
[TBL] [Abstract][Full Text] [Related]
29. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.
Choi JK; Oh HM; Lee S; Park JW; Khang D; Lee SW; Lee WS; Rho MC; Kim SH
Toxicol Appl Pharmacol; 2013 May; 269(1):72-80. PubMed ID: 23499868
[TBL] [Abstract][Full Text] [Related]
30. The skin barrier, atopic dermatitis and allergy: a role for Langerhans cells?
Callard RE; Harper JI
Trends Immunol; 2007 Jul; 28(7):294-8. PubMed ID: 17544846
[TBL] [Abstract][Full Text] [Related]
31. Multipolarity of cytokine axes in the pathogenesis of atopic dermatitis in terms of age, race, species, disease stage and biomarkers.
Nomura T; Honda T; Kabashima K
Int Immunol; 2018 Aug; 30(9):419-428. PubMed ID: 29518197
[TBL] [Abstract][Full Text] [Related]
32. Atopic dermatitis: therapeutic concepts evolving from new pathophysiologic insights.
Jung T; Stingl G
J Allergy Clin Immunol; 2008 Dec; 122(6):1074-81. PubMed ID: 18992925
[TBL] [Abstract][Full Text] [Related]
33. Molecular basis of atopic dermatitis.
Bonness S; Bieber T
Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):382-6. PubMed ID: 17873576
[TBL] [Abstract][Full Text] [Related]
34. Insight into newly discovered innate immune modulation in atopic dermatitis.
Park CO; Noh S; Jin S; Lee NR; Lee YS; Lee H; Lee J; Lee KH
Exp Dermatol; 2013 Jan; 22(1):6-9. PubMed ID: 23088736
[TBL] [Abstract][Full Text] [Related]
35. Biologic Therapy for Atopic Dermatitis: Moving Beyond the Practice Parameter and Guidelines.
Boguniewicz M
J Allergy Clin Immunol Pract; 2017; 5(6):1477-1487. PubMed ID: 29122151
[TBL] [Abstract][Full Text] [Related]
36. Early immunologic changes during the onset of atopic dermatitis.
Brunner PM
Ann Allergy Asthma Immunol; 2019 Aug; 123(2):152-157. PubMed ID: 30953783
[TBL] [Abstract][Full Text] [Related]
37. Atopic dermatitis: new evidence on the role of allergic inflammation.
Heratizadeh A
Curr Opin Allergy Clin Immunol; 2016 Oct; 16(5):458-64. PubMed ID: 27490127
[TBL] [Abstract][Full Text] [Related]
38. Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis.
Yang G; Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326002
[TBL] [Abstract][Full Text] [Related]
39. Atopic dermatitis displays stable and dynamic skin transcriptome signatures.
Möbus L; Rodriguez E; Harder I; Stölzl D; Boraczynski N; Gerdes S; Kleinheinz A; Abraham S; Heratizadeh A; Handrick C; Haufe E; Werfel T; Schmitt J; Weidinger S;
J Allergy Clin Immunol; 2021 Jan; 147(1):213-223. PubMed ID: 32615169
[TBL] [Abstract][Full Text] [Related]
40. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis.
Elias PM; Schmuth M
Curr Opin Allergy Clin Immunol; 2009 Oct; 9(5):437-46. PubMed ID: 19550302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
